Literature DB >> 6367854

Quality control of estrogen receptor assays in The Netherlands.

T Koenders, T J Benraad.   

Abstract

Lyophilized receptor-positive tissue powders and cytosols, prepared from calf uterus and human breast tumor tissue, are used to assess the validity of routine dextran-coated charcoal estrogen receptor assays. Since 1978 lyophilized reference preparations have been analyzed twice yearly by 18 laboratories in the Netherlands. During 8 consecutive trials 20 different lyophilized samples were studied. The inter-laboratory variability of estrogen receptor results decreased with time. Most laboratories found receptor values around the median value of all groups together, though some participants consistently reported estrogen receptor values that were higher or lower than the median. The variability of estrogen receptor results between labs seemed to be associated with cytosol dilution, determination of non-specific binding, concentration and volume of dextran-coated charcoal, and the use of single dose assays or Scatchard analysis. The agreement on the presence or absence of estrogen receptors was more than 98% for lyophilized reference samples with high receptor content. For samples with low receptor content 85% agreement was observed, while 12% of the assays performed on receptor-negative material were reported to be estrogen receptor-positive. The use of the same protein determination (Coomassie Brilliant Blue) and human serum albumin standard has decreased the interlaboratory variation coefficient of the protein results to 7.5%.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6367854     DOI: 10.1007/bf01806699

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Estradiol and progesterone receptor activities in stored lyophilised target tissue.

Authors:  A J Koenders; J Geurts-Moespot; K H Kho; T J Benraad
Journal:  J Steroid Biochem       Date:  1978-10       Impact factor: 4.292

2.  Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. Workshop, held on 16-17 March, 1979, in the Netherlands Cancer Institute.

Authors: 
Journal:  Eur J Cancer       Date:  1980-11       Impact factor: 9.162

3.  Estradiol receptor activity in lyophilized calf uterus and human breast tumor tissue.

Authors:  T Benraad; A Koenders
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

4.  Investigation on the thermostability of steroid hormone receptors in lyophilized calf uterine tissue powder.

Authors:  H Bojar; W Staib; K Beck; J Pilaski
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

5.  Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.

Authors:  R Paridaens; R J Sylvester; E Ferrazzi; N Legros; G Leclercq; J C Heuson
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

6.  Quantitative estrogen receptor analyses: the response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval.

Authors:  M E Lippman; J C Allegra
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

7.  Quality control of estradiol receptor analysis: the United Kingdom experience.

Authors:  R J King
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

8.  Standardization of steroid receptor assays in human breast cancer--II. Samples with low receptor content.

Authors:  A Koenders; S M Thorpe
Journal:  Eur J Cancer Clin Oncol       Date:  1983-10

9.  A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays.

Authors:  D T Zava; A Wyler-von Ballmoos; A Goldhirsch; W Roos; A Takahashi; U Eppenberger; S Arrenbrecht; G Martz; G Losa; F Gomez; C Guelpa
Journal:  Eur J Cancer Clin Oncol       Date:  1982-08

10.  Results of the Italian interlaboratory quality control program for estradiol receptor assay.

Authors:  S Fumero; G P Berruto; D Pelizzola; S Grilli; C Buttazzi; G Di Fronzo; E Ronchi; C Bozzetti; P Mori; G Concolino; A Marocchi; G Robustelli Della Cuna; C Zibera; G Cerrutti; A Ros; A Piffanelli
Journal:  Tumori       Date:  1981-08
View more
  1 in total

1.  Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.

Authors:  Françoise Révillion; Carole Puech; Fanja Rabenoelina; Dany Chalbos; Jean-Philippe Peyrat; Gilles Freiss
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.